NCI-MATCH Trial (Molecular Analysis for Therapy Choice)
Information about the NCI-MATCH precision medicine trial, in which patients with advanced solid tumors and lymphomas are assigned to treatment arms based on the molecular profiles of their disease.
Media Type: Html
- SourceUrl: https://www.cancer.gov/node/829631/syndication
- Syndication ID: 3521
- Language: English
- Source: National Cancer Institute (NCI)
- Date Syndication Captured: Wednesday, July 29, 2015 at 04:31 PM
- Date Syndication Updated: Monday, August 05, 2019 at 07:43 PM
Embed Code Snippet
To get the embed code snippet please Login.
